Trials / Active Not Recruiting
Active Not RecruitingNCT05026632
NPI-002 Intravitreal Implant for the Delay of Cataract Progression
Safety and Efficacy of NPI-002 Intravitreal Implant for the Delay of Cataract Progression in Patients Undergoing Vitrectomy
- Status
- Active Not Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Nacuity Pharmaceuticals, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will examine the safety and efficacy NPI-002 intravitreal implants post vitrectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NPI-002 Intravitreal Implant | Implant inserted during vitrectomy. |
Timeline
- Start date
- 2022-01-27
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2021-08-30
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05026632. Inclusion in this directory is not an endorsement.